Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selman A Ali

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Iranian Journal of Immunology : IJI|July 1, 2014
CTL responses to DCs stimulated with leishmania antigens detected by DCs expressing Leishmania gp63Hossein Rezvan, Ali Khodadadi, Selman A Ali
Cancer Immunology, Immunotherapy : CII|June 16, 2004
Escape from immunotherapy: possible mechanisms that influence tumor regression/progressionMurrium Ahmad, Robert C Rees, Selman A Ali
Iranian Journal of Parasitology|January 20, 2023
Inhibitory Effects of <i>Leishmania Mexicana</i> Infection on MHC-I Expression in Bone Marrow Derived Dendritic CellsHossein Rezvan, Selman A Ali, Sahar Hamoon Navard
International Journal of Molecular and Cellular Medicine|July 15, 2024
Biological Activity of Mouse OX40L-Igg Purified With Two Novel ResinsHossein Rezvan, Selman A Ali, Sahar Hamoonnavard, et al.
Comparative Immunology, Microbiology and Infectious Diseases|July 2, 2023
Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c miceHossein Rezvan, Selman A Ali, Sahar Hamoon Navard, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2005
Immunotherapeutic potential of DISC-HSV and OX40L in cancerDeepak P Assudani, Murrium Ahmad, Geng Li, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Current Opinion in Molecular Therapeutics|March 9, 2002
Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancerRobert C Rees, Stephanie McArdle, Shahid Mian, et al.
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
International Journal of Cancer|February 22, 2005
Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSFMurrium Ahmad, Robert C Rees, Stephanie E McArdle, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Iranian Journal of Immunology : IJI|July 1, 2014
CTL responses to DCs stimulated with leishmania antigens detected by DCs expressing Leishmania gp63Hossein Rezvan, Ali Khodadadi, Selman A Ali
Cancer Immunology, Immunotherapy : CII|June 16, 2004
Escape from immunotherapy: possible mechanisms that influence tumor regression/progressionMurrium Ahmad, Robert C Rees, Selman A Ali
Iranian Journal of Parasitology|January 20, 2023
Inhibitory Effects of <i>Leishmania Mexicana</i> Infection on MHC-I Expression in Bone Marrow Derived Dendritic CellsHossein Rezvan, Selman A Ali, Sahar Hamoon Navard
International Journal of Molecular and Cellular Medicine|July 15, 2024
Biological Activity of Mouse OX40L-Igg Purified With Two Novel ResinsHossein Rezvan, Selman A Ali, Sahar Hamoonnavard, et al.
Comparative Immunology, Microbiology and Infectious Diseases|July 2, 2023
Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c miceHossein Rezvan, Selman A Ali, Sahar Hamoon Navard, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2005
Immunotherapeutic potential of DISC-HSV and OX40L in cancerDeepak P Assudani, Murrium Ahmad, Geng Li, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Current Opinion in Molecular Therapeutics|March 9, 2002
Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancerRobert C Rees, Stephanie McArdle, Shahid Mian, et al.
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
International Journal of Cancer|February 22, 2005
Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSFMurrium Ahmad, Robert C Rees, Stephanie E McArdle, et al.
Pageof 2